Loading…

Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation

Abstract Allogeneic stem cell transplantation is considered to be a curative treatment modality in patients with chronic myelogenous leukemia. However patients are at risk for relapse years after transplantation. Currently we present two patients who relapsed 16 and 24 years after allogeneic bone ma...

Full description

Saved in:
Bibliographic Details
Published in:Leukemia research 2009-09, Vol.33 (9), p.1291-1293
Main Authors: Sekhri, Arunabh, Liu, Delong, Rasul, Muhammad, Ahmed, Nasir, Ahmed, Tauseef, Seiter, Karen
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Allogeneic stem cell transplantation is considered to be a curative treatment modality in patients with chronic myelogenous leukemia. However patients are at risk for relapse years after transplantation. Currently we present two patients who relapsed 16 and 24 years after allogeneic bone marrow transplantation, respectively. These patients emphasize the need for long term follow-up of such patients.
ISSN:0145-2126
1873-5835
DOI:10.1016/j.leukres.2009.03.010